Filing Flows

Filing Flows › E.W. Scripps (SSP) › Q2 2026 › vs Q1 2026

E.W. Scripps (SSP) Q2 2026 vs Q1 2026 (quarter over quarter)

E.W. Scripps's revenue fell $26.5M (-5%) from $517M in Q1 2026 to $490M in Q2 2026. The biggest changes: Distribution −$28.4M (-15%); Other +$1.8M (+21%); Advertising +$154K (0%).

E.W. Scripps, Q2 2026: revenue $490M (-9% year over year), operating margin -236.0%, net loss $1.2B, operating cash flow $13.6M. The chart draws each line against Q1 2026, the increases inside each band.

E.W. Scripps: what changed, Q2 2026 vs Q1 2026E.W. Scripps: what changed, Q2 2026 vs Q1 2026Costs & expenses$1.2BOther operating costs$1.2BWorking capital & other$1.2BOperating cash sources$1.2BOperating costs$1.2BNet loss$1.1BNet loss absorbed$1.1BIncome tax benefit$54.4MDistribution−$28.4MInterest & other, net$21.5M

Every line

LineQ2 2026Q1 2026Change%
Core advertising$286M$306M−$19.4M-6%
Political$29.7M$10.1M$19.6M+194%
Advertising$316M$316M$154K0%
Distribution$164M$192M−$28.4M-15%
Other$10.7M$8.8M$1.8M+21%
Revenue$490M$517M−$26.5M-5%
Income tax benefit$57.0M$2.7M$54.4M21×
Net loss$1.2B$1.8M$1.1B643×
Costs & expenses$1.7B$521M$1.2B+226%
Operating costs$1.6B$492M$1.2B+235%
Interest & other, net$50.7M$29.2M$21.5M+74%
Cost of revenue$294M$311M−$16.7M-5%
SG&A$147M$146M$1.3M+0.9%
Other operating costs$1.2B$35.5M$1.2B34×
Operating cash sources$1.2B$5.3M$1.2B220×
Depreciation & amortization$35.1M$35.3M−$286K-0.8%
Share-based compensation$6.0M$6.5M−$500K-8%
Working capital & other$1.1B−$36.6M$1.2B—
Net loss absorbed$1.2B$1.8M$1.1B643×
Operating cash flow$13.6M$3.5M$10.1M+288%
Capital expenditures$16.5M$3.2M$13.4M+424%
Negative free cash flow (OCF − capex)$2.9M−$350K$3.3M—

Questions

How much did E.W. Scripps's revenue grow quarter over quarter in Q2 2026?

E.W. Scripps's revenue fell $26.5M (-5%) from $517M in Q1 2026 to $490M in Q2 2026.

What drove E.W. Scripps's revenue change in Q2 2026?

Distribution −$28.4M (-15%); Other +$1.8M (+21%); Advertising +$154K (0%).

Q2 2026 results → · Compare in the interactive Sankey →